A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
D001095:Arachidonic Acids / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D003981:Diazoxide / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology*; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D011458:Prostaglandins E / Q000097:blood; D011460:Prostaglandins F / Q000097:blood; D013928:Thromboxane A2 / Q000097:blood*; D013931:Thromboxanes / Q000097:blood*
D001095:Arachidonic Acids; D011458:Prostaglandins E; D011460:Prostaglandins F; D013931:Thromboxanes; D006830:Hydralazine; D013928:Thromboxane A2; D004176:Dipyridamole; D003981:Diazoxide